Blockonomi

TLDR:
Ethereum and Solana proposals could reduce annual inflation and slow new token supply growth.
Grayscale projects ETH inflation near 0.4% and SOL inflation near 1.1% by 2031 if changes pass.
Lower inflation could reduce staking rewards as fewer new tokens enter circulation across both networks.
Solana’s proposals appear to have broader community agreement, according to Grayscale’s research.
Ethereum and Solana are moving toward lower token inflation as both networks consider changes that could reduce future supply growth. The proposals could make ETH and SOL scarcer over the coming years if their communities approve the changes.
By 2031, projected annual inflation could fall below current gold supply growth and U.S. consumer inflation. The changes would also alter how staking rewards reach token holders across both networks.
Ethereum and Solana Weigh Lower Inflation
Ethereum and Solana support major blockchain activity, including stablecoins and tokenized assets. Their native tokens trade as digital commodities, with supply and demand shaping their market value.
According to Grayscale, proposed code changes could reduce annual token inflation on both networks. Lower supply growth would leave fewer new tokens entering circulation over time.
Grayscale estimates that Ethereum and Bitcoin could reach about 0.4% annual supply inflation by 2031. Solana could reach roughly 1.1%, assuming the proposed changes take effect.
The estimates assume the networks implement the proposed tokenomics changes without other supply adjustments. Bitcoin provides a useful comparison because its projected inflation would also remain near 0.4% annually.
Those figures would sit below gold’s estimated 1.8% annual supply growth and U.S. CPI inflation at 3.3%. The comparison shows how the proposals could change the supply profile of ETH and SOL.
The lower issuance rates would not automatically determine token prices, since demand would remain a separate market variable. Still, the proposed changes directly target the amount of new ETH and SOL entering circulation.
Ethereum $ETH and Solana $SOL could be getting scarcer.
New proposals on both networks aim to burn more tokens and cut inflation, reducing future supply. If they pass, annual inflation for ETH and SOL could fall below gold (1.8%) and U.S. CPI (3.3%) by 2031.
More on protocol… pic.twitter.com/svyoXq8WzI
— Grayscale (@Grayscale) August 14, 2026
ETH and SOL Staking Rewards Could Change
The proposals remain under discussion within the respective blockchain communities. Grayscale said Solana’s proposals appear to have broader agreement and may have a higher chance of implementation.
Staking rewards rely partly on new token issuance, meaning lower inflation would reduce the number of tokens distributed to stakers. That change could alter the return profile for participants who secure each network.
Unstaked ETH and SOL holders could benefit from reduced token issuance if scarcity supports stronger market prices. Stakers would face a different calculation because lower rewards could offset any potential price increase.
Grayscale’s research also points to the technical nature of the proposed changes, particularly Ethereum’s staking model. The outcome depends on whether each community approves the changes and how the new parameters affect token supply.
Governance decisions will determine whether the proposed reductions become part of each network’s operating rules.
The post Why Ethereum and Solana Supply Growth Could Drop Sharply by 2031: Grayscale appeared first on Blockonomi.

TLDR:
CLARITY Act passage odds have dropped to 10% as Senate negotiations remain unresolved.
Senate leaders delayed the CLARITY Act vote after political and banking disputes stalled negotiations.
SEC exemptions could provide temporary crypto rules while Congress struggles to pass legislation.
CFTC action on prediction markets adds another front to the wider U.S. crypto regulatory debate.
The odds of the CLARITY Act becoming law in 2026 have fallen to 10%, according to Galaxy Research. The Senate delayed action after negotiations failed to resolve several political and industry disputes.
Meanwhile, the SEC and CFTC are advancing regulatory measures while Congress remains stalled. The shift could leave U.S. crypto companies relying on agency action before lawmakers establish permanent rules.
CLARITY Act Passage Faces Senate Roadblocks
The CLARITY Act cleared a bipartisan Senate Banking Committee markup in May, raising expectations for progress before August. However, several disputes later weakened support for the bill among senators.
Galaxy Research pointed to unresolved ethics controls concerning government officials and crypto-related activities. Pressure from community banks also created resistance to provisions involving stablecoin-related business models.
Lawmakers also debated developer protections under the Blockchain Regulatory Certainty Act. Concerns from illicit finance groups added another obstacle during negotiations.
Senate Majority Leader John Thune ultimately declined to schedule a vote before the August recess. The Senate now expects to consider the CLARITY Act after lawmakers return on September 14.
Galaxy Research said the September session leaves limited time for the legislation. The Senate plans to adjourn around October 2 for midterm election activity.
Galaxy Research: Odds of CLARITY Act Passage This Year Decline
Galaxy Research stated that the likelihood of the U.S. crypto market structure bill, the CLARITY Act, passing in 2026 is declining. Uncertainty surrounding the legislation has prompted the SEC and CFTC to accelerate… pic.twitter.com/J7psdruD6l
— Wu Blockchain (@WuBlockchain) August 15, 2026
SEC and CFTC Advance Crypto Regulation
The stalled CLARITY Act has coincided with renewed regulatory activity at federal agencies. Galaxy Digital said the SEC had been preparing two major crypto exemptions.
One proposal, called Reg Crypto, would establish a pathway for public cryptoasset issuance. The Innovation Exemption would address secondary trading of tokenized securities within decentralized finance.
Bloomberg previously reported that the SEC was preparing both measures. However, the agency delayed the initiatives following resistance from traditional securities industry participants.
Galaxy noted that the SEC appeared close to releasing the exemptions again this week. The agency later delayed the Innovation Exemption and canceled a planned open meeting.
The CFTC has also intensified efforts around prediction markets and event contracts. The agency issued an emergency order challenging New York Attorney General Letitia James’ attempt to block Kalshi nationwide.
According to Galaxy Research, agency measures could temporarily address regulatory gaps while Congress remains gridlocked. However, those measures lack the durability of legislation and could change under another administration.
Galaxy Research expects the SEC to publish Reg Crypto, the Innovation Exemption, or both within coming weeks or months. The agency’s actions could therefore shape U.S. crypto regulation while the CLARITY Act remains uncertain.
The post Galaxy Digital Cuts CLARITY Act Passage Odds to 10% as Senate Vote Slips appeared first on Blockonomi.

TLDR
Sidus Space Q2 revenue drops 54% to $583,000 as operating losses remain elevated
SIDU stock drops after hours despite ending the regular session 2.36% higher
Sidus Space ends June with $166.5 million in cash and no outstanding term debt
A $100 million share offering strengthens Sidus Space’s balance sheet in Q2
LizzieSat testing and Fortis VPX integration advance key mission milestones
Sidus Space (NASDAQ: SIDU) reported weaker second-quarter revenue while losses continued across its space and defense operations. SIDU stock closed 2.36% higher at $2.60 before falling 8.85% after hours to $2.37. The company also strengthened its cash position and advanced its next LizzieSat spacecraft during the quarter.
Sidus Space, Inc., SIDU
Sidus Space Q2 Revenue Falls as Expenses Rise
Sidus Space generated $583,000 in second-quarter revenue, down 54% from $1.3 million one year earlier. The company linked the decline to the timing of revenue recognition under fixed-price milestone contracts. Lower contract activity therefore reduced reported sales during the three months ending June 30.
Cost of revenue fell 47% to $1.2 million from $2.3 million during the previous-year quarter. However, Sidus Space still recorded a $630,000 gross loss during the latest reporting period. That result improved 39% from the $1 million gross loss recorded one year earlier.
Meanwhile, selling, general, and administrative expenses increased 19% to $5.1 million from $4.3 million. Adjusted EBITDA produced a $5.1 million loss, compared with a $3.9 million loss last year. Net loss improved 15% to $4.8 million, reducing the year-over-year loss by $844,000.
Sidus Space Builds Cash Position Through Share Offering
Sidus Space ended June with $166.5 million in cash and reported no outstanding term debt. The balance sheet improvement followed a major capital raise completed during the second quarter. Management plans to use the stronger financial position to support commercialization and technology development.
The company closed a registered direct offering on May 29 involving 19.69 million Class A shares. Sidus priced the shares, or equivalent pre-funded warrants, at $5.08 each. The transaction generated approximately $100 million in gross proceeds before fees and other offering expenses.
Sidus also secured expected membership in three FTSE Russell indexes during the annual June reconstitution. The additions covered the Russell 2000, Russell 3000, and Russell Microcap Indexes. Those changes expanded the company’s exposure across portfolios that follow major Russell benchmarks.
LizzieSat Development Advances Toward Commercial Operations
Operationally, Sidus completed vibration testing for its next LizzieSat spacecraft during the second quarter. The company conducted the qualification work at Element U.S. Space and Defense’s Orlando facility. The testing marked an important environmental milestone before future spacecraft deployment activities.
Sidus also integrated its proprietary Fortis VPX Maxima computing platform into the upcoming LizzieSat spacecraft. The system combines processing hardware, reconfigurable technology, navigation capabilities, and onboard mission computing functions. Sidus designed the platform to support autonomous processing across space, air, land, and maritime applications.
The company continues shifting its focus from technology development toward recurring government and commercial contracts. Sidus highlighted opportunities across defense, intelligence, satellite services, and related technology markets. It also appointed Alan Khalili as chief financial officer, effective July 27.
Sidus Space Expands Space and Defense Technology Strategy
Sidus Space develops satellite hardware, mission systems, data services, and technology for commercial and government customers. Its LizzieSat platform supports hosted payloads and other missions through a flexible small-satellite architecture. The company has continued developing proprietary systems while seeking contracts that can produce recurring revenue.
The latest quarter showed a sharp difference between Sidus Space’s financial resources and current operating performance. Revenue declined substantially, while operating expenses and adjusted EBITDA losses remained elevated. Improved gross losses and a stronger cash balance provided additional resources for future execution.
Sidus presented the quarterly results after the regular trading session on August 14. The company also scheduled a conference call to discuss the quarter and its broader business progress. Its next financial updates will show whether recent technology milestones translate into stronger commercial revenue.
The post Sidus Space, Inc. (SIDU) Stock: Q2 Revenue Drops 54% as Losses Persist appeared first on Blockonomi.

TLDR
Paramount wins WBD merger clearance across 68 countries after eight months.
Mexico becomes the latest market to approve Paramount’s proposed WBD merger.
Twelve state attorneys general remain the final obstacle to the WBD transaction.
Global regulators found no major competition concerns across key media markets.
Paramount says further legal delays could raise costs and disrupt operations
Paramount Skydance (PSKY) gained 1.71% to $10.14, then added 0.39% to $10.18 after regular trading. The move followed another regulatory milestone for Paramount’s planned Warner Bros. Discovery acquisition. Paramount has now secured required regulatory clearances across 68 countries, leaving a multistate lawsuit as the remaining obstacle.
Paramount Skydance Corporation Class B Common Stock, PSKY
Paramount Skydance Secures Global WBD Merger Clearances
Paramount said competition authorities across 68 jurisdictions have approved the proposed Warner Bros. Discovery transaction. The eight-month review covered major markets across Europe, North America, Asia, Africa, Australia, and South America. Mexico became the latest jurisdiction to approve the combination and completed Paramount’s required global regulatory review.
Authorities in the European Union, United Kingdom, Australia, Canada, Brazil, China, and COMESA examined the transaction. The United States Department of Justice also reviewed the planned combination under federal competition rules. These reviews covered film production, theatrical distribution, television networks, streaming services, and content licensing.
Paramount said the companies could complete the transaction without the remaining state-level legal challenge. California and 11 other state attorneys general continue to challenge the merger through litigation. Paramount has urged the states to negotiate a settlement instead of continuing toward a trial.
Regulators Reject Major Competition Concerns
Several regulators found that the combined company would continue facing substantial competition across entertainment markets. The United Kingdom competition authority found no realistic prospect of substantially weaker competition after the merger. European regulators also considered streaming services important competitors against traditional television networks.
The United States Department of Justice recognized growing competitive pressure from streaming platforms on broadcast and cable networks. Meanwhile, Australian regulators examined competition across theatrical distribution and film production. They identified Disney, Sony, Universal, Amazon MGM, StudioCanal, and independent companies as significant competitors.
Brazilian authorities treated theatrical film distribution as one broad market rather than separating the largest releases. COMESA also described theatrical distribution as competitive and driven heavily by individual successful films. These findings differ from the narrower competition arguments presented by the 12 state attorneys general.
State Lawsuit Remains Final Barrier to WBD Deal
Paramount now faces a legal dispute rather than another international regulatory approval process. The company says the continuing case could increase penalty payments, legal expenses, and operational disruption. A prolonged delay could also affect planning across both companies before their proposed combination.
The company has offered commitments and concessions while seeking an agreement with the participating states. Paramount also plans to maintain significant film output after completing the Warner Bros. Discovery acquisition. The company has committed to releasing at least 30 high-quality films annually across the combined business.
The Warner Bros. Discovery deal would combine two major entertainment groups with large film and television operations. Paramount Skydance emerged from the 2025 combination between Skydance Media and the former Paramount Global. The WBD transaction would further expand Paramount’s position across studios, television networks, streaming platforms, and entertainment libraries.

The post Paramount Skydance (PSKY) Stock: WBD Merger Wins Clearance in 68 Countries appeared first on Blockonomi.

TLDR
Reddit stock jumps 12% as S&P 500 inclusion fuels a strong market rally today
RDDT surges after S&P confirms Reddit will join the S&P 500 on August 18, 2026
Reddit replaces AvalonBay in the S&P 500 before trading opens on August 18
Passive S&P 500 funds may need to buy RDDT shares ahead of its index entry
Sun Communities will join the S&P MidCap 400 as Webster Financial exits index
Reddit Inc. (RDDT) stock jumped 12.63% to $178.09 after S&P Dow Jones Indices announced its S&P 500 inclusion. The shares held strong gains after briefly climbing above $183 during intraday trading. Reddit will officially join the benchmark before trading begins on Tuesday, August 18.
Reddit, Inc., RDDT
Reddit Stock Rallies After S&P 500 Addition
S&P Dow Jones Indices selected Reddit to replace AvalonBay Communities in the S&P 500. The change gives Reddit membership in one of the most tracked United States equity benchmarks. The announcement triggered a sharp rise in Reddit shares during Friday trading.
Reddit will enter the index under the Communication Services sector with its existing RDDT ticker. The company has expanded its presence in public markets since completing its initial public offering. Its S&P 500 addition now marks another major step in its development as a listed company.
Index membership can also affect trading because funds tracking the S&P 500 must match its holdings. Therefore, passive funds may need to purchase Reddit shares before the index change takes effect. The required portfolio adjustments can increase trading activity around an index addition.
AvalonBay Exit Creates Opening for Reddit
Reddit will replace AvalonBay Communities after Equity Residential agreed to acquire the real estate company. The transaction remains subject to final closing conditions before completion. S&P has already scheduled AvalonBay’s removal before the August 18 market opening.
Equity Residential currently holds membership in the S&P 500 and will remain in the benchmark after the transaction. Following the merger, the combined company will operate under the Vivmark Residential name. The company will also trade under the new VMRK ticker after completing the planned combination.
The merger removes the need for two separate S&P 500 positions following the companies’ combination. As a result, S&P selected Reddit to take AvalonBay’s position within the large-cap index. The move also shifts that position from Financials into the Communication Services sector.
S&P Index Changes Extend to MidCap 400
S&P Dow Jones Indices also announced separate changes involving the S&P MidCap 400 benchmark. Sun Communities will replace Webster Financial before trading begins on Thursday, August 20. Sun Communities operates within the Real Estate sector and trades under the SUI ticker.
Webster Financial will leave the MidCap 400 because Banco Santander plans to acquire the company. The transaction remains dependent on final conditions before the companies complete the deal. Santander trades in Madrid and New York under the SAN ticker.
The scheduled changes follow S&P’s standard process of adjusting index membership after major corporate transactions. Reddit’s addition stands out because its shares responded sharply after the announcement. The August 18 inclusion will place RDDT alongside established large-cap companies across the United States market.
The post Reddit, Inc. (RDDT) Stock: Surge 12% on S&P 500 Inclusion appeared first on Blockonomi.

TLDR
PrimeEnergy Q2 net income doubles to $6.5M as stronger oil prices lift results.
PNRG rises 0.46% to $196.48 after retreating from a sharp intraday spike.
Negative Permian gas prices weigh on revenue despite stronger oil earnings.
PrimeEnergy begins drilling 24 horizontal wells across Martin and Upton counties.
Company ends Q2 with $28.7M cash, no bank debt and expanded share buybacks.
PrimeEnergy Resources reported stronger second-quarter earnings as higher oil prices offset severe weakness in Permian natural gas pricing. PNRG stock rose 0.46% to $196.48 after retreating from an intraday surge above $215. The company also expanded drilling activity while maintaining a debt-free balance sheet and continuing share repurchases.
PrimeEnergy Resources Corporation, PNRG
PrimeEnergy Q2 Profit Rises as Oil Prices Strengthen
PrimeEnergy posted second-quarter net income of $6.5 million, compared with $3.2 million during the same period last year. Basic earnings reached $4.06 per share, up from $1.94 per share in the 2025 quarter. First-half net income declined to $10.9 million from $12.4 million one year earlier.
Strong oil pricing supported quarterly results despite lower production and difficult natural gas market conditions. PrimeEnergy realized an average oil price of $98.85 per barrel, compared with $56.96 one year earlier. Oil revenue reached $40.6 million and provided a major offset against weaker gas revenue.
Natural gas pricing remained a significant drag as Permian Basin takeaway capacity stayed constrained. PrimeEnergy realized an average gas price of negative $3.53 per Mcf during the second quarter.Negative natural gas revenue reached $9.2 million and reduced the benefit from higher oil prices.
PrimeEnergy Expands Drilling and Share Repurchases
PrimeEnergy started drilling 24 horizontal wells across Martin and Upton Counties during the second quarter. The company expects first production from those wells during the fourth quarter of 2026. Its development program remains focused primarily on the Midland Basin region of West Texas.
In Upton County, PrimeEnergy joined Apache in developing 12 wells across several producing formations. The company holds an average ownership interest of about 41.8% in the project. PrimeEnergy expects to invest approximately $34.1 million in the wells and related production facilities.
PrimeEnergy joined Oxyrock in drilling 12 horizontal wells in Martin County. The company expects to spend only about $120,000 on those wells. That smaller commitment will provide additional geological and production information covering several targeted formations.
PrimeEnergy Maintains Strong Liquidity With No Bank Debt
PrimeEnergy ended June with $28.7 million in cash, up from $7.4 million at the end of 2025. The company also reported no outstanding bank debt at the end of the quarter. Furthermore, its revolving credit facility provided additional financial flexibility for future development spending.
The borrowing base under that credit facility reached $105 million effective August 3, 2026. PrimeEnergy currently has access to the full amount because it carries no outstanding borrowings. That liquidity supports its planned $52 million investment across 28 horizontal wells during 2026.
PrimeEnergy also continued returning capital through its long-running share repurchase program. The company bought 31,290 shares for about $5.5 million during the second quarter. Its board later approved another 300,000 shares, leaving 340,544 shares available for future repurchases.

The post PrimeEnergy Resources (PNRG) Stock: Rise as Q2 Profit Doubles and Oil Prices Surge appeared first on Blockonomi.

TLDR
PMGC Q2 revenue jumps 92% sequentially to about $1.31 million in June quarter
Total assets rise 40% from March to approximately $36.6 million by late June
Cash climbs to a record $18.1 million as PMGC strengthens its balance sheet
A&B Aerospace adds revenue and expands PMGC’s aerospace manufacturing reach
Six-month revenue hits $1.99 million, more than triple full-year 2025 revenue
PMGC Holdings (ELAB) rose 2.62% to $0.9202 as the company reported stronger second-quarter revenue and balance sheet growth. Revenue increased 92% sequentially to about $1.31 million during the quarter ended June 30, 2026. Meanwhile, total assets climbed to approximately $36.6 million following acquisitions and expansion across operating subsidiaries.
PMGC Holdings Inc., ELAB
PMGC Holdings Q2 Revenue Rises 92% Sequentially
PMGC generated approximately $1.31 million in second-quarter revenue, compared with no reported revenue during the same 2025 period. Sequentially, revenue increased about 92% from approximately $682,000 recorded during the first quarter of 2026. The company benefited from contributions across its manufacturing, aerospace, bioscience, defense, and specialty packaging operations.
Six-month revenue reached approximately $1.99 million through June, showing continued expansion across PMGC’s operating businesses. That figure represented about 3.4 times the company’s entire fiscal 2025 revenue of approximately $590,000. Therefore, recently acquired businesses have started making a larger contribution to consolidated revenue during 2026.
A&B Aerospace contributed revenue for part of the second quarter after PMGC completed the acquisition on May 11. The Southern California company operates precision machining and aerospace manufacturing facilities under an AS9100D certification. Its customers include Boeing, Honeywell, and Moog across major aerospace and industrial supply chains.
PMGC Assets Climb to $36.6 Million
PMGC reported approximately $36.6 million in total assets at the end of June. That represented a 40% increase from approximately $26 million recorded at the end of March. Assets also increased 184% from approximately $12.87 million reported at the end of 2025.
Shareholders’ equity reached approximately $17.4 million, rising 38% from about $12.6 million during the previous quarter. Equity also increased 122% from year-end 2025 and approximately 92% compared with the prior-year period. The company’s capital base expanded alongside its acquisition activity and operating growth.
Cash and cash equivalents reached approximately $18.1 million at the end of the second quarter. The figure increased from approximately $14.4 million in March and $5.4 million at the end of 2025. Meanwhile, net working capital improved to approximately $6.2 million from $5.1 million in the previous quarter.
Aerospace Acquisition Expands PMGC Operating Platform
PMGC has built its current structure through acquisitions across several industrial and technology-focused businesses. The company now owns five operating businesses spanning aerospace manufacturing, specialty packaging, biosciences, defense technology, and related industrial markets. This diversified structure gives PMGC revenue exposure across several industries rather than relying on one operating segment.
A&B Aerospace generated approximately $4.5 million in trailing 12-month revenue when PMGC completed the acquisition. The business also operated with positive cash flow at closing, adding an established revenue source to PMGC’s portfolio. Its aerospace capabilities also expand PMGC’s presence within commercial and defense-related manufacturing supply chains.
PMGC plans to continue assessing acquisition opportunities across its existing markets and other industries. Management intends to target businesses that can strengthen operations and contribute long-term value across the holding company’s portfolio. The latest quarterly figures show that acquisition activity has already expanded PMGC’s revenue base and balance sheet during 2026.

The post PMGC Holdings (ELAB) Stock: Q2 Revenue Jumps 92% as Assets Reach $36.6M appeared first on Blockonomi.

TLDR
Rocket Lab secures a $397M Space Force contract for Flatellites deployment.
RKLB slips 0.49% as defense contract growth strengthens government business.
Flatellites support airborne threat tracking through low-latency space systems.
Rocket Lab’s 2026 U.S. defense contracts now total roughly $943 million overall.
Neutron and GHOST expand Rocket Lab’s launch options for national defense missions.
Rocket Lab (RKLB) shares slipped 0.49% to $79.71 on Friday after losing momentum above the $80 level. However, the company secured a $397 million U.S. Space Force contract for a new satellite fleet. The award expands Rocket Lab’s role in national security space programs and supports its growing defense business.
Rocket Lab USA, Inc., RKLB
Rocket Lab Secures $397 Million Space Force Contract
The Space Force selected Rocket Lab to design, build, and launch satellites under its SB-AMTI program. The program aims to improve space-based tracking of airborne threats across contested operating environments. Rocket Lab will provide satellites carrying sensors and communication systems designed for rapid threat detection.
The company calls the new spacecraft Flatellites because their compact design supports stacked launches into orbit. Their flat structure allows launch vehicles to carry more spacecraft within available payload space. Rocket Lab also designed the satellites for larger orbital constellations requiring efficient deployment.
Each satellite will include low-latency communications and high-bandwidth systems for transmitting tracking information. The spacecraft will also carry sensors designed to identify and follow airborne targets. Consequently, the system could strengthen military awareness across regions where traditional surveillance faces operational limits.
Defense Contracts Expand Rocket Lab’s Government Business
The $397 million award represents Rocket Lab’s largest announced national defense contract this year. Rocket Lab has disclosed four major U.S. government defense contracts during 2026. Together, those agreements carry a combined value of about $943 million.
The Defense Department previously awarded Rocket Lab $190 million for 20 HASTE test launches. Separately, the Space Force awarded $90 million for two satellites operating in geostationary orbit. Another $266 million agreement covers up to 18 missile-defense launches from Alaska.
These contracts strengthen Rocket Lab’s position across spacecraft manufacturing, satellite systems, and specialized launch services. They also increase the company’s exposure to U.S. defense spending on missile detection and space infrastructure. Meanwhile, Washington continues expanding space-based defense capabilities under broader missile-defense initiatives.
Neutron and GHOST Support Rocket Lab’s Defense Strategy
Rocket Lab plans to launch the Flatellites in stacked configurations aboard its developing Neutron rocket. Neutron will provide greater lift capacity than the company’s existing Electron launch vehicle. The company designed Neutron to compete for larger commercial, government, and national security missions.
Rocket Lab currently expects Neutron to debut near the end of 2026 or during early 2027. The rocket will feature partial reusability while supporting larger payloads and satellite constellation deployments. Therefore, the Flatellites program could become an important early government mission for the vehicle.
Rocket Lab has also introduced GHOST, a portable launch system for Electron and HASTE missions. The system uses deployable infrastructure that can support launches from temporary or mobile locations. Together, Neutron and GHOST broaden Rocket Lab’s ability to serve fixed and responsive national security missions.

The post Rocket Lab (RKLB) Stock: Slightly Drop as Space Force Awards $397M Deal for Flatellites appeared first on Blockonomi.

TLDR
Jasper Therapeutics completes Kira merger, raises $132M for pipeline growth.
Combined firm targets PNH, transplant, and autoimmune disease programs ahead.
KP-104 renal trial data and FDA meetings expected in late 2026.
Briquilimab and KP-701 advance toward BLA and IND filings in 2027.
Jasper Therapeutics posts $2.8M net loss, funds operations through 2028.
JSPR shares changed hands at $0.8223 on Friday, down 4.73% intraday. The move comes despite the completed merger with Kira Pharmaceuticals and a fresh $132 million financing round. Jasper Therapeutics now controls a combined pipeline spanning complement and antibody therapies for immune-mediated diseases.
Jasper Therapeutics, Inc., JSPR
Kira Merger and $132 Million Financing
Jasper Therapeutics completed its acquisition of Kira Pharmaceuticals on July 16, 2026. The deal combined two clinical-stage biotech firms through an all-stock transaction. Kira previously operated as a Cayman-based company focused on complement therapies.
Jasper Therapeutics simultaneously closed a private placement of non-voting convertible preferred stock. Affinity Asset Advisors and Ikarian Capital co-led the round, and other life science investors joined. The financing generated roughly $132 million in gross proceeds for the combined company.
President and CEO Jeet Mahal said the merger unites Jasper Therapeutics and Kira Pharmaceuticals around a shared mission. He noted the capital extends the runway through the second half of 2028. Mahal added that the combined firm now holds resources across the United States and China.
Consolidated Pipeline Advances Toward Key Milestones
Jasper Therapeutics is advancing KP-104, also known as vensobafusp alfa, as its lead complement asset. The bifunctional biologic targets both the alternative and terminal complement pathways. Researchers are testing KP-104 in a Phase 2 basket trial for rare renal disorders.
Interim data from Stage 1 of that trial should arrive in the fourth quarter of 2026. Jasper Therapeutics also plans an end-of-Phase 2 meeting with the FDA. The company expects to announce next steps for paroxysmal nocturnal hemoglobinuria treatment in early 2027.
Briquilimab, a late-stage anti-KIT antibody, remains central to the transplant and immunology programs. Positive long-term data in SCID patients support a planned pre-BLA meeting with regulators. The company also targets a Phase 1 filing for KP-701 in early 2027.
Second Quarter Financial Results
Jasper Therapeutics reported cash and cash equivalents of $7.3 million as of June 30, 2026. Research and development expense reached $5.1 million for the quarter. General and administrative costs totaled $4.1 million during the same period.
The company posted a net loss of $2.8 million for the second quarter. That figure equals a basic and diluted loss of $0.10 per share. Jasper Therapeutics attributed spending to continued clinical development across its pipeline.
The recent $132 million raise now supplements these quarterly figures significantly. Combined with Kira’s assets, the company enters the second half of 2026 with more resources. Jasper Therapeutics aims to fund operations through 2028 without additional financing.

The post Jasper Therapeutics, Inc. (JSPR) stock: Climbs on Kira Merger and $132M Raise as Pipeline Consolidates appeared first on Blockonomi.

TLDR
Jasper Therapeutics completes Kira merger, raises $132M for pipeline growth.
Combined firm targets PNH, transplant, and autoimmune disease programs ahead.
KP-104 renal trial data and FDA meetings expected in late 2026.
Briquilimab and KP-701 advance toward BLA and IND filings in 2027.
Jasper Therapeutics posts $2.8M net loss, funds operations through 2028.
JSPR shares changed hands at $0.8223 on Friday, down 4.73% intraday. The move comes despite the completed merger with Kira Pharmaceuticals and a fresh $132 million financing round. Jasper Therapeutics now controls a combined pipeline spanning complement and antibody therapies for immune-mediated diseases.
Jasper Therapeutics, Inc., JSPR
Kira Merger and $132 Million Financing
Jasper Therapeutics completed its acquisition of Kira Pharmaceuticals on July 16, 2026. The deal combined two clinical-stage biotech firms through an all-stock transaction. Kira previously operated as a Cayman-based company focused on complement therapies.
Jasper Therapeutics simultaneously closed a private placement of non-voting convertible preferred stock. Affinity Asset Advisors and Ikarian Capital co-led the round, and other life science investors joined. The financing generated roughly $132 million in gross proceeds for the combined company.
President and CEO Jeet Mahal said the merger unites Jasper Therapeutics and Kira Pharmaceuticals around a shared mission. He noted the capital extends the runway through the second half of 2028. Mahal added that the combined firm now holds resources across the United States and China.
Consolidated Pipeline Advances Toward Key Milestones
Jasper Therapeutics is advancing KP-104, also known as vensobafusp alfa, as its lead complement asset. The bifunctional biologic targets both the alternative and terminal complement pathways. Researchers are testing KP-104 in a Phase 2 basket trial for rare renal disorders.
Interim data from Stage 1 of that trial should arrive in the fourth quarter of 2026. Jasper Therapeutics also plans an end-of-Phase 2 meeting with the FDA. The company expects to announce next steps for paroxysmal nocturnal hemoglobinuria treatment in early 2027.
Briquilimab, a late-stage anti-KIT antibody, remains central to the transplant and immunology programs. Positive long-term data in SCID patients support a planned pre-BLA meeting with regulators. The company also targets a Phase 1 filing for KP-701 in early 2027.
Second Quarter Financial Results
Jasper Therapeutics reported cash and cash equivalents of $7.3 million as of June 30, 2026. Research and development expense reached $5.1 million for the quarter. General and administrative costs totaled $4.1 million during the same period.
The company posted a net loss of $2.8 million for the second quarter. That figure equals a basic and diluted loss of $0.10 per share. Jasper Therapeutics attributed spending to continued clinical development across its pipeline.
The recent $132 million raise now supplements these quarterly figures significantly. Combined with Kira’s assets, the company enters the second half of 2026 with more resources. Jasper Therapeutics aims to fund operations through 2028 without additional financing.

The post Jasper Therapeutics, Inc. (Nasdaq: JSPR) stock climbs on Kira merger and $132M raise as pipeline consolidates appeared first on Blockonomi.

TLDR
Trinity Biotech stock rises 1.87% after $7M Perceptive Advisors investment news.
Trinity Biotech regains Nasdaq bid price compliance after 10-day qualifying streak.
Trinity Biotech secures $2.5M in new debt and $4.5M in capitalised interest.
Trinity Biotech eyes CGM+ growth as financial flexibility strengthens this quarter.
Trinity Biotech reports $10.5M preliminary revenue amid ongoing operational transformation.
TRIB shares climbed to $11.96, up 1.87%, on Friday. The rally followed news that Perceptive Advisors will inject $7 million into the company. Trinity Biotech also confirmed it has regained compliance with Nasdaq’s minimum bid price rule.
Trinity Biotech plc, TRIB
Perceptive Advisors Deepens Investment Commitment
Perceptive Advisors, a major healthcare-focused investment firm, expanded its backing of Trinity Biotech this week. The firm is the company’s largest financial investor and its primary lender. This latest round adds fresh capital and signals continued confidence in the strategy.
The $7 million investment includes $2.5 million in new debt funding. It also includes $4.5 million in capitalised interest under an amended financing agreement. Together, the funds strengthen liquidity and give Trinity Biotech more financial flexibility.
Trinity Biotech plans to use the funding to support several initiatives. These include the CGM+ continuous glucose monitoring platform and the core diagnostics business. The company will also apply funds toward Trinovium, its liquid cooling subsidiary for AI data centres.
Nasdaq Bid Price Compliance Restored
Nasdaq confirmed on August 7, 2026 that the company met its minimum bid price requirement again. The rule falls under Nasdaq Listing Rule 5450(a)(1). This marks a key milestone in the ongoing turnaround.
The compliance stemmed from ten consecutive business days of qualifying closing prices. The company’s American Depositary Shares closed at $1.00 or higher each day. This stretch ran from July 24 to August 6, 2026.
Regaining compliance removes a major regulatory concern for the company. It also reduces the risk of delisting from the Nasdaq exchange. The achievement adds to a string of positive developments this quarter.
Strategic Priorities and Financial Outlook
Trinity Biotech reported preliminary revenue of about $10.5 million for the quarter ended June 30, 2026. This figure stays broadly consistent with the prior quarter. CEO John Gillard called the funding and compliance milestone “important positive developments” for the company.
The strategic repositioning has now reached its later stages. The shift reflects structural change across global healthcare markets. It also reflects advances in sensor technology, artificial intelligence, and digital healthcare delivery.
The company continues to explore technology acquisitions and new partnerships. These efforts target firms working on diagnostics and diabetes management tools. Trinity Biotech aims to complement its wearable CGM+ biosensor through these deals.
The post Trinity Biotech plc (TRIB) Stock: Jumps as Perceptive Advisors Backs $7M Investment and Nasdaq Compliance Is Restored appeared first on Blockonomi.

Key Highlights
Starting August 23, Binance will prohibit transactions with HTX and ten additional cryptocurrency platforms.
All dealings connected to the blacklisted platforms will undergo mandatory compliance assessments and possible wallet limitations.
European Union regulatory sanctions have imposed operational constraints on HTX and multiple other digital currency services.
Earlier this month, Binance had already implemented access restrictions on five separate sanctioned platforms.
Platform users must refrain from any direct or indirect fund transfers with the designated entities.
Beginning August 23, Binance will cease facilitating any transactions connected to HTX alongside ten other cryptocurrency service providers. These enforcement actions stem from recent regulatory sanctions and compliance directives targeting various digital asset platforms. All transactions associated with the designated entities will undergo thorough compliance assessments and may trigger temporary wallet access limitations.
Binance Broadens Platform Access Restrictions Starting Aug. 23
According to Binance’s announcement, the August 23 enforcement will encompass Rapira, Aifory Pro, ABCeX, WhiteBird, and NoOnecrypto. Additional platforms on the restriction list include Tradex, Monease, BitPapa, Exnode, HTX and EXMO. Platform users must completely avoid any direct or indirect fund movements involving these services beyond the specified deadline.
Any transaction flagged under these restrictions may enter a pending status while Binance conducts comprehensive compliance verification. During this review period, the exchange reserves the right to impose limitations on affected digital wallets. Furthermore, such transactions may constitute violations of the platform’s service agreement.
The cryptocurrency exchange attributed these enforcement measures to regulatory obligations across multiple operating jurisdictions. Binance emphasized that these protocols strengthen compliance frameworks while safeguarding both user assets and platform security. Similar access restrictions affecting five additional service providers were implemented earlier this month.
European Union Sanctions Create Compliance Challenges for HTX and Peer Platforms
These August enforcement actions emerge following European Union regulatory measures targeting cryptocurrency platforms allegedly connected to Russia-focused sanctions circumvention activities. The EU formalized its most recent sanctions framework on July 23. Multiple platforms identified in Binance’s restriction announcement also feature prominently in the bloc’s new transaction prohibition directives.
The EU’s enforcement scope encompasses HTX, EXMO, Rapira, BitPapa, Aifory Pro, WhiteBird, NoOnecrypto and Exnode. These regulatory measures officially activate on August 23. They categorically prohibit affected European individuals and corporate entities from engaging in any direct or indirect financial activities with specified service providers.
Regulatory authorities have extended restrictions to include cryptocurrency platforms operating beyond Russian borders when sanctions evasion risks are identified. The package introduces transaction prohibitions affecting additional financial service organizations. The comprehensive enforcement framework targets financial infrastructure, energy sector operations, and Russia-affiliated distribution channels.
HTX Confronts Intensifying Regulatory Examination
HTX was already navigating regulatory challenges prior to the European enforcement measures becoming effective. United Kingdom authorities formally designated Huobi Global S.A. on May 26. British regulators connected the organization to financial operations allegedly supporting sanctioned Russian interests.
HTX challenged the breadth of that designation and attempted to distinguish its exchange infrastructure from Huobi Global S.A. Nevertheless, British sanctions officials subsequently applied ownership attribution standards to the exchange platform. This clarification substantially elevated compliance obligations for organizations handling HTX-related transactions.
Blockchain intelligence organizations subsequently conducted investigations into activities associated with the exchange and its wallet infrastructure. TRM Labs documented recurring modifications involving HTX hot wallet configurations across multiple prominent blockchain ecosystems. HTX characterized these adjustments as standard security protocols rather than sanctions circumvention tactics.
Binance Previously Implemented Restrictions Against Additional Sanctioned Entities
Binance rolled out initial restrictions targeting Shelbit and Aban Tether Exchange on August 7. Subsequently, on August 13, the platform added A7 Nigeria, A7 Africa, and PilotFinance Ltd to the restricted entities roster. These enforcement actions preceded the more extensive August 23 group implementation.
United States authorities sanctioned Shelbit and Aban Tether citing alleged Iran-connected financial operations. U.S. regulatory bodies linked both platforms to transaction activities involving sanctioned Iranian networks and cryptocurrency exchanges. Shelbit firmly denied all allegations concerning money laundering operations, terrorism financing activities, and deliberate sanctions violations.
Binance currently maintains a total of 16 restricted entities across the three August enforcement dates. Users must completely avoid transmitting or accepting funds involving these entities following their respective implementation deadlines. The enforcement policy applies to both direct fund transfers and transactions channeled indirectly through intermediary services.

The post Binance Implements Access Ban on HTX and 10 Additional Cryptocurrency Exchanges appeared first on Blockonomi.

Key Highlights
Shares decline following announcement of $94.5M CyberCatch purchase
Acquisition strengthens continuous compliance and cyber risk monitoring
Strategic move positions company in expanding cybersecurity market
Deal includes automated security testing and regulatory compliance tools
Integration enhances secure infrastructure with quantum-resistant encryption
Shares of Datavault AI dropped 1.69% to close at $0.3185 on Friday, retreating from earlier session highs during late-afternoon trading. The pullback came after the company disclosed its planned $94.5 million all-cash purchase of CyberCatch Holdings. This strategic acquisition significantly enhances the firm’s cybersecurity portfolio by incorporating continuous compliance monitoring and advanced cyber risk assessment technologies.
Datavault AI Inc., DVLT
Stock Retreats Following Major Acquisition News
Datavault AI announced it will purchase all outstanding shares of CyberCatch through a court-sanctioned arrangement under British Columbia corporate regulations. The definitive agreement covers approximately 26.8 million existing shares of the target company. Additionally, any remaining dilutive securities held by CyberCatch will be resolved using a cashless exercise mechanism.
Standard conditions apply to the transaction, including approval from boards of directors, stock exchanges, regulatory bodies, and shareholders of both companies. Once finalized, CyberCatch will function as a wholly-owned subsidiary operating from San Diego, California. Sai Huda, who founded CyberCatch, will assume the role of subsidiary president and work directly under Datavault AI Chief Executive Officer Nathaniel Bradley.
Despite initial positive market reaction, the stock reversed course during afternoon hours after the acquisition disclosure. This transaction marks a substantial enhancement of Datavault AI’s comprehensive data infrastructure and security framework. The deal brings an established cybersecurity solution into the company’s expanding technology ecosystem.
Security Capabilities Significantly Enhanced
CyberCatch delivers continuous cybersecurity compliance monitoring, automated penetration testing, and comprehensive cyber risk evaluation through its software-as-a-service platform. The system performs ongoing verification of mandatory security controls and proactively detects vulnerabilities before malicious actors can take advantage of system weaknesses. It also provides real-time assessment of cyber hygiene practices and breach probability across organizations operating in regulated sectors.
The platform addresses multiple security frameworks applicable to defense contractors, healthcare providers, financial institutions, manufacturers, educational institutions, and additional regulated sectors. Supported standards include NIST guidelines, Cybersecurity Maturity Model Certification, ISO 27001, HIPAA regulations, PCI DSS requirements, and various global compliance frameworks. CyberCatch continuously evaluates organizations from external attack vectors, internal threat scenarios, and social engineering angles.
Management intends to incorporate CyberCatch functionality throughout its current data management, computing, and secure networking infrastructure. The acquired technology will enhance DataValue, DataScore, and Information Data Exchange services following deal closure. Additionally, CyberCatch will deliver ongoing security compliance verification for workloads supporting government agencies and regulated commercial clients.
Strategic Positioning in Expanding Market
This acquisition positions Datavault AI to capitalize on the rapidly expanding global cybersecurity sector. Research firm Gartner forecasted worldwide information security expenditures would hit $213 billion throughout 2025. Accelerating attack velocities and increasingly automated cyber threats have driven heightened demand for continuous testing capabilities and expedited risk identification.
CyberCatch has additionally pioneered encryption solutions tailored for next-generation post-quantum security challenges. Its MARS-MABE framework manages data access through specific user attributes while enabling immediate access revocation when necessary. The organization aims to fortify this technology against security vulnerabilities that may emerge from advancing quantum computing capabilities.
Company leadership anticipates CyberCatch will serve as a comprehensive security layer spanning its growing technology suite. The combined entity connects secure computing resources, data analytics capabilities, cybersecurity testing tools, and compliance management functions under a unified operational framework. Consequently, this acquisition accelerates Datavault AI’s strategic initiative to dominate the secure data infrastructure space and penetrate regulated industry verticals.
The post Datavault AI (DVLT) Stock Dips Following $94.5M CyberCatch Acquisition Announcement appeared first on Blockonomi.

Key Takeaways
Hyperscale Data stock tumbles 16.37% following disclosure of a $43 million Bitcoin liquidation
Company offloads approximately 685 BTC while maintaining around 275 Bitcoin in reserves
Proceeds from the sale designated for Michigan AI data center infrastructure development
Executives confirm continued commitment to Bitcoin mining and potential future acquisitions
Fresh capital injection supports data center project as GPUS hits intraday lows
Shares of Hyperscale Data (GPUS) nosedived 16.37% to $0.0945 following the company’s announcement of a significant Bitcoin treasury drawdown. The firm liquidated approximately 685 Bitcoin, generating roughly $43 million in proceeds earmarked for strengthening working capital and financing its Michigan-based data center facility. After completing the transaction, Hyperscale Data maintains approximately 275 Bitcoin in its corporate treasury while executives reaffirm their commitment to digital asset operations.
Hyperscale Data, Inc., GPUS
Share Price Tumbles Following Cryptocurrency Liquidation
Hyperscale Data announced its intention to allocate the majority of proceeds from the Bitcoin sale toward accelerating development of its Michigan data center operations. The company additionally intends to deploy funds for optimizing its capital structure, including potential debt reduction and equity strengthening initiatives. GPUS shares continued their downward trajectory throughout the trading session, hovering near daily lows after the disclosure.
The cryptocurrency liquidation provides Hyperscale Data with substantial working capital as infrastructure expenditures accelerate at its data center facility. Company leadership views the Michigan infrastructure project as a cornerstone asset underpinning its strategic growth initiatives. This capital reallocation represents a pivot from cryptocurrency reserves toward tangible operational assets.
Nevertheless, the Bitcoin disposal doesn’t signal a complete departure from digital currency operations according to management guidance. Hyperscale Data intends to maintain its Bitcoin mining operations and potentially rebuild treasury holdings when market dynamics and financial circumstances prove favorable. Any future cryptocurrency acquisitions will be contingent upon mining productivity, working capital needs, Bitcoin valuation trends, infrastructure investments, and prevailing economic conditions.
AI Computing Facility Secures Capital Injection
Hyperscale Data has amplified its commitment to expanding computational capabilities at its Michigan facility throughout 2026. The company has previously disclosed details of a multi-year service contract with an undisclosed infrastructure client. This foundational agreement encompasses roughly 20 megawatts of computing power under a decade-long commitment.
The contract structure includes dual five-year renewal provisions that could substantially enhance the agreement’s aggregate financial value. Hyperscale Data has projected potential revenues exceeding $1.2 billion should the client activate both extension clauses. These revenue projections remain contingent upon client decisions and successful capacity deployment timelines at the Michigan location.
The agreement additionally permits the client to request an additional 32 megawatts of capacity within the contract’s initial 24-month period. Such an expansion could potentially elevate the project’s comprehensive contract value above $3 billion when accounting for all available extension periods. Accordingly, executive leadership has elevated infrastructure financing as a strategic priority amid escalating construction and equipment procurement requirements at the Michigan campus.
Digital Asset Holdings Support Corporate Financing Approach
This recent Bitcoin transaction marks the second significant cryptocurrency liquidation by Hyperscale Data in recent months. During July, the company divested approximately 100 Bitcoin while simultaneously channeling additional resources toward its Michigan infrastructure initiative. The firm also secured a Bitcoin-collateralized lending arrangement to facilitate construction costs and equipment acquisitions.
Prior to this latest transaction, Hyperscale Data reportedly maintained approximately 1,006 Bitcoin following the earlier disposal. The current sale of 685 Bitcoin constitutes a major reduction from those previously disclosed reserves. The company currently reports maintaining roughly 275 Bitcoin after executing this most recent liquidation.
Notwithstanding the diminished cryptocurrency balance, Bitcoin mining operations continue as an integral component of Hyperscale Data’s operational and treasury framework. Mining activities provide the organization with an alternative mechanism for accumulating digital assets without exclusive reliance on direct market acquisitions. GPUS currently balances this approach with intensified data center capital deployment as management redirects resources toward infrastructure expansion.
The post Hyperscale Data (GPUS) Stock Drops 16% Following $43M Bitcoin Liquidation appeared first on Blockonomi.

Key Highlights
AMD shares increased approximately 1% during Friday’s premarket session following the announcement of a $5 billion bond issuance for AI infrastructure
This represents the chipmaker’s most substantial bond offering to date, eclipsing the $1.5 billion raised just months earlier in March 2025
The company projects server revenue will surge over 80% during the second half of 2026, with at least 70% growth anticipated for 2027
Major tech players OpenAI, Meta, and Anthropic have each pledged 1 gigawatt of AMD computing capacity
Helios AI rack shipments are scheduled to commence in September, with significant revenue acceleration expected in the fourth quarter
Shares of Advanced Micro Devices (AMD) gained approximately 1% during Friday’s premarket session, trading at $485.50, following the chipmaker’s disclosure of plans to secure as much as $5 billion through a bond issuance earmarked for artificial intelligence and data center expansion initiatives.
The proposed capital raise comprises a four-tranche investment-grade bond structure featuring maturity dates spanning three to ten years. Ultimate offering size will be determined by market appetite. Funds raised will support general corporate activities, potentially including existing debt refinancing.
Should the offering reach its full capacity, it would mark AMD’s most significant dollar-denominated bond transaction in company history. The chipmaker’s previous investment-grade issuance secured $1.5 billion during March 2025.
Broader market sentiment supported AMD’s gains, with Nasdaq futures climbing 0.27% and S&P 500 futures advancing 0.10% concurrent with the premarket movement. July’s Consumer Price Index registered at 3.4%, as moderating inflation figures bolstered investor confidence.
The semiconductor company recently delivered robust quarterly financial results that exceeded both revenue and profit forecasts. Nevertheless, shares experienced a pullback following the earnings release, partially attributed to Elon Musk’s public endorsement of Nvidia processors for SpaceX infrastructure.
Ambitious Revenue Projections
During its Technology Leadership Forum 2026, AMD unveiled ambitious expansion objectives. The semiconductor manufacturer forecasts server revenue will escalate by more than 80% throughout the latter half of 2026, with growth exceeding 70% projected for 2027.
The company’s comprehensive data center segment, encompassing artificial intelligence solutions, is anticipated to expand well beyond 100% during the coming year.
AMD estimates the server CPU marketplace will reach a valuation of $220 billion by decade’s end. The chipmaker is pursuing a revenue share exceeding 50% within that segment.
Company leadership anticipates agentic computing will constitute approximately two-thirds of this market opportunity. Agentic AI systems demand greater CPU processing capabilities, a domain where AMD maintains competitive strength complementing its GPU portfolio.
AMD’s preliminary 2027 server revenue projections already exceed the total addressable server market from 2025 by roughly 20%.
Product Launches and Strategic Partnerships
The semiconductor manufacturer intends to initiate component shipments for its Helios AI rack systems in September. Management anticipates a revenue acceleration during the fourth quarter, with further momentum building into the first quarter.
Both OpenAI and Meta have secured commitments for 1 gigawatt each of AMD computing infrastructure. Anthropic has committed to 1 gigawatt with aspirations to expand toward 2 gigawatts.
Additional deployments are expected through Microsoft Azure, Oracle Cloud Infrastructure, and various cloud service providers.
Financial analysts maintain predominantly optimistic outlooks on AMD. The company’s Helios processor architecture is widely expected to generate substantial returns beginning in Q4, with executive leadership asserting performance advantages over Nvidia’s current product lineup.
AMD stock concluded trading with a marginal 0.02% increase on August 13, 2026, before adding another 0.43% during premarket activity on August 14.
The post AMD (AMD) Stock Gains Momentum With Record $5B Bond Offering for AI Infrastructure appeared first on Blockonomi.

TLDR
Upland reports $49.1M Q2 revenue as divestitures continue reducing annual sales.
Non-GAAP net income rises 18% to $6.6M while GAAP loss widens on impairment.
Upland adds 81 new customers and expands relationships with 200 existing clients.
Free cash flow nearly doubles to $5.3M as quarter-end cash reaches $31 million.
Full-year guidance targets up to $196.1M in revenue with a 27% EBITDA margin.
Upland Software stock traded at $5.90, down 3.28%, after the company reported mixed second-quarter results and stronger cash generation. Second-quarter revenue reached $49.1 million, while non-GAAP net income increased and free cash flow nearly doubled from last year. Upland also added 81 customers as management continued focusing the business on knowledge management, content, and enterprise software.
Upland entered 2026 after divesting several non-strategic assets during 2025, which reduced its continuing revenue base. The company now centers its strategy on enterprise knowledge, content, and data products with stronger AI-related positioning. This transition places customer expansion, margins, and cash generation at the center of its operating reset.
Upland Software, Inc., UPLD
Revenue Declines While Adjusted Profitability Improves
Upland generated $49.1 million in total revenue during Q2 2026, down 8% from $53.4 million one year earlier. Subscription and support revenue fell 9% to $46.2 million, mainly because 2025 divestitures reduced the comparable revenue base. Still, reported revenue exceeded the midpoint of management’s previous quarterly guidance and maintained a substantial recurring subscription contribution.
GAAP net loss widened to $35.3 million from $13.0 million during the same quarter of 2025. A non-cash goodwill impairment recorded in June drove much of that increase and weighed heavily on reported GAAP earnings. Non-GAAP net income increased 18% to $6.6 million from $5.6 million, showing stronger adjusted profitability.
Adjusted EBITDA reached $12.8 million, compared with $13.6 million during the second quarter of 2025. The adjusted EBITDA margin improved to 26% from 25%, despite the year-over-year decline in total reported revenue. That margin result supported Upland’s effort to concentrate resources around software products offering stronger growth and operating leverage.
Customer Wins Support Upland Software Strategy
Upland added 81 new customers during the quarter, including seven accounts classified as major customers. The company also expanded relationships with 200 existing customers, and 19 of those deals qualified as major expansions. Those additions gave Upland a broader commercial base as it continued reshaping its portfolio following last year’s divestitures.
The company’s knowledge management products also received external industry recognition during the quarter. Upland RightAnswers appeared in Forrester’s second-quarter knowledge management landscape, while several products earned recognition in G2 reports. Upland Panviva, RightAnswers, BA Insight, and InterFAX featured across categories tied to knowledge management and enterprise software workflows.
Upland continues positioning enterprise knowledge and content as central parts of its product strategy. Its software aims to organize company information and make that information usable across employees, workflows, and automated systems. More than 1,100 enterprise customers use Upland products, giving the company an established base for further product expansion.
Cash Flow Strengthens as Guidance Points Lower
Operating cash flow increased to $5.4 million from $3.3 million in the prior-year quarter. Free cash flow reached $5.3 million, nearly doubling from $2.7 million, while quarter-end cash stood at $31.0 million. The stronger cash generation provided a financial counterweight to the larger GAAP loss and continuing revenue contraction.
For Q3 2026, Upland expects total revenue between $45.7 million and $48.7 million. Adjusted EBITDA should range from $11.9 million to $13.4 million, with a 27% margin at the midpoint. Management expects midpoint revenue to decline 7% annually, mainly because completed divestitures continue affecting year-over-year comparisons.
For full-year 2026, Upland forecasts total revenue between $190.1 million and $196.1 million. Adjusted EBITDA should reach $49.8 million to $52.8 million, with the midpoint representing a 12% annual decline. Upland now faces the task of pairing customer growth and cash generation with steadier revenue and continued margin discipline.
The post Upland Software, Inc. (UPLD) Stock: AI Focus Drives Customer Wins and Margin Strength appeared first on Blockonomi.

Key Takeaways
Regulatory 13G filing reveals Elon Musk’s ownership of 48.4% of SpaceX as of June 30, 2026
Musk’s 6.42 billion-share position carries a valuation exceeding $900 billion based on current trading prices
Despite holding under 50% economic ownership, Musk commands over 82% of voting control
Musk clarified that significant portions of his stake remain contingent on ambitious performance milestones
Norway’s sovereign wealth fund disclosed ownership of 0.05%, valued at approximately $1.2 billion
New regulatory documents have shed light on the complete extent of Elon Musk’s ownership position in SpaceX, including critical information regarding which portions have fully vested.
Elon Musk disclosed ownership of 6.4 billion $SPCX shares in a new SEC filing, giving him a 48% stake in SpaceX.
His position is worth ~$908B at current prices. pic.twitter.com/DfbZco9PYS
— Shay Boloor (@StockSavvyShay) August 13, 2026
According to the 13G filing lodged on Thursday, Musk owns 6.42 billion shares of SpaceX Class A common stock dated June 30. This represents a 48.4% ownership position in the aerospace manufacturer.
Based on prevailing market valuations, this holding exceeds $900 billion in total value. However, Musk immediately contested that figure’s accuracy.
In a statement posted on X, he clarified that certain shares “only vest on extremely crazy good outcomes for SpaceX,” indicating his actual vested ownership percentage falls below what the regulatory document might imply.
Breakdown of Musk’s Ownership Structure
The share distribution is organized across multiple classifications. Approximately 849.5 million consist of Class A shares maintained in trusts where Musk functions as the designated trustee. An additional 3.92 billion are Class B shares within those identical trust arrangements.
Musk directly owns 1.30 billion restricted Class B shares, while maintaining options encompassing another 350 million Class B shares. According to the filing, he possesses exclusive voting authority and dispositive control across all 6.42 billion shares.
Though his economic ownership remains marginally beneath 50%, Musk wields more than 82% of SpaceX’s aggregate voting power. This concentration provides him decisive influence over corporate strategy.
All 6.4 billion of Musk’s shares face restrictions preventing sale until June 2027.
Volatile Performance Following SpaceX Public Debut
SpaceX completed its initial public offering on June 12, generating $85.7 billion in capital and momentarily driving the company’s market capitalization beyond $2 trillion. The offering priced shares at $135.
The subsequent trajectory proved turbulent. Stock prices declined to $105.11 during early August when approximately 911.5 million insider-held shares became tradable for the first time.
At that juncture, shares had plummeted over 50% from their June 16 high of $225.64. The price also traded roughly 20% beneath the IPO level.
This downturn followed SpaceX’s inaugural earnings disclosure, which revealed capital expenditures exceeding double the company’s revenue. Nevertheless, the reported $7.8 billion in revenue surpassed analyst projections.
Share prices have since regained partial momentum. SpaceX stock finished Thursday at $141.29, declining 3.33% during the session, before advancing to $143.40 in Friday’s premarket activity. The stock has appreciated 3.83% over the trailing month.
Another significant revelation accompanied Musk’s filing. Norway’s Government Pension Fund Global reported holding a 0.05% ownership stake in SpaceX, valued at slightly above $1.2 billion as of June 30.
The post Elon Musk Controls 48.4% of SpaceX Valued at Over $900 Billion, New Filing Reveals appeared first on Blockonomi.

TLDR
OTLK stock drops 12.24% after Q3 losses and a $51.1 million public share offering.
Outlook Therapeutics posts a $20.3 million Q3 net loss for fiscal year 2026.
The company raised about $51.1 million through a large August public offering.
Management targets a U.S. LYTENAVA launch before the end of calendar year 2026.
LYTENAVA could exceed $500 million in annual U.S. sales by 2030, management says.
Outlook Therapeutics (OTLK) shares fell 12.24% to $0.7800 after the company reported third-quarter losses and detailed a major stock offering. The decline followed fresh financial results that showed another quarterly loss despite improved adjusted figures. The company continued preparations for the planned United States launch of LYTENAVA before year-end.
Outlook Therapeutics, Inc., OTLK
Outlook Therapeutics Reports $20.3 Million Q3 Loss
Outlook Therapeutics reported a $20.3 million net loss for its fiscal third quarter ended June 30. The loss equaled $0.15 per basic and diluted share during the reporting period. A year earlier, the company posted a $20.2 million loss and a $0.55 per-share loss.
However, adjusted results showed some improvement compared with the same quarter last year. Outlook Therapeutics recorded an adjusted net loss of $10.9 million, equal to $0.09 per share. The company reported a $15.8 million adjusted loss and $0.44 per share one year earlier.
The adjusted figures excluded several accounting charges linked to debt, warrants, and promissory notes. These items included a $7 million loss from changes in the fair value of warrant liabilities. Outlook Therapeutics also excluded debt extinguishment costs and changes related to promissory note valuations.
$51 Million Offering Adds Pressure to OTLK Stock
Outlook Therapeutics completed a public offering after the June quarter ended, strengthening its available cash position. The company sold 55,555,556 common shares alongside warrants covering another 55,555,556 shares. It priced each share and accompanying warrant at a combined public offering price of $0.99.
The transaction generated approximately $51.1 million in net proceeds after fees and other estimated offering expenses. However, the large share issuance increased the company’s outstanding equity and created additional dilution concerns. OTLK stock responded sharply, falling to $0.7800 during Friday’s session.
Before the financing, Outlook Therapeutics held $11.2 million in cash and cash equivalents on June 30. That balance excluded the proceeds from the August public offering. The new capital gives the company additional funding as commercial launch expenses increase.
LYTENAVA Launch Strategy Remains Central to Outlook
Outlook Therapeutics continues preparations for LYTENAVA’s planned United States commercial launch before the end of 2026. The FDA-approved ophthalmic bevacizumab targets wet age-related macular degeneration, commonly known as wet AMD. The company expects the product to compete within the established anti-VEGF treatment market.
Outlook Therapeutics is expanding payer discussions and increasing commercial supply ahead of the planned launch. The company is also building a specialized sales organization focused on retina practices with strong adoption potential. Management projects annual United States LYTENAVA sales could exceed $500 million by 2030.
The company also plans to apply for a permanent HCPCS reimbursement code by October 1, 2026. Outside the United States, Outlook Therapeutics already markets LYTENAVA across Germany, Austria, and the United Kingdom. It also plans launches in the Netherlands during 2026 and Switzerland during 2027.

The post Outlook Therapeutics (OTLK) Stock: Tumbles After LYTENAVA Launch Plans and $51 Million Public Offering appeared first on Blockonomi.

TLDR
Northrop Grumman secured a $158.8 million contract modification with the U.S. Department of War
Contract W58RGZ-26-C-0009 finalizes terms and pricing for an existing defense agreement
Operations will be conducted at the company’s Illinois facility in Rolling Meadows
Complete funding from Fiscal 2026 revolving funds was allocated upon contract award
Investment research firm Zacks identifies NOC as attractive value opportunity with strong Style Scores
On August 13, 2026, Northrop Grumman (NOC) finalized a $158.8 million contract modification with the U.S. Department of War. The defense contractor’s shares advanced 0.64% during trading.
The agreement modification, totaling precisely $158,831,128, pertains to contract designation W58RGZ-26-C-0009. This modification addresses the definitization process for a pre-existing arrangement with the Department of War.
The definitization procedure represents the finalization of all contractual elements, including pricing structures, terms, and operational conditions for agreements that were previously undefinitized. Essentially, this transitions the arrangement from a temporary status to a completely formalized commitment.
Operations stemming from this modification will take place at Northrop’s Illinois-based facility in Rolling Meadows. The scheduled completion date for the contract stands at August 13, 2026.
The entire amount of $158,831,128 from Fiscal 2026 revolving funds received full obligation upon award. This indicates the financial resources have been fully allocated.
Army Contracting Command, operating from Redstone Arsenal in Alabama, served as the contracting authority for this transaction.
Zacks Identifies NOC as Strong Value Opportunity
In independent analysis, Zacks Equity Research spotlighted NOC as an attractive value investment on August 14, 2026. The research firm employs its proprietary Style Scores methodology to evaluate equities across value, growth, and momentum dimensions.
NOC received positive assessments within Zacks’ Value Style Score framework, which analyzes metrics such as P/E ratios, PEG multiples, Price/Sales, and Price/Cash Flow indicators. An elevated value score indicates the equity may be undervalued relative to its fundamental worth.
The Zacks Rank, the firm’s comprehensive rating system, relies primarily on earnings estimate revisions. Securities receiving a #1 (Strong Buy) designation have delivered average annual returns of 23.94% since the system’s 1988 inception, per company data.
The VGM Score represents a composite metric blending value, growth, and momentum factors, serving as a crucial indicator alongside the rank framework. Equities earning a Rank of #1 or #2 combined with Style Scores of A or B represent the most compelling investment opportunities.
Contract Background
Northrop Grumman maintains its headquarters in Rolling Meadows, Illinois. The corporation ranks among America’s premier defense contractors, operating an extensive portfolio spanning aerospace, ground systems, naval platforms, space technologies, and cybersecurity solutions.
This contractual modification supplements Northrop’s ongoing collaboration with the U.S. Army. Redstone Arsenal’s Army Contracting Command oversees substantial defense acquisition operations.
The $158.8 million agreement doesn’t constitute fresh work assignments, but instead formalizes pricing structures and contractual terms for initiatives already in progress.
Revolving funds, utilized for this contract’s obligation, represent a government financial instrument enabling funds to be recycled as expenditures occur and resources are recaptured.
Specific details regarding the program or defense platform associated with this contract modification remain undisclosed.
NOC shares concluded the August 13, 2026 trading session with a 0.64% gain.
The post Northrop Grumman (NOC) Stock Gains Ground Following $158.8M Army Contract Modification appeared first on Blockonomi.

Key Highlights
CRWD reached a record peak of $227.21, with current trading near $225.53
Annual performance shows 110.82% increase, significantly exceeding S&P 500 returns
Strong fundamentals include 23% revenue expansion and 75% gross margins
Quarterly results scheduled for August 26 with projected 26% EPS growth
Analyst community elevates price objectives to $230 from Citizens and Stifel
On August 14, 2026, CrowdStrike shares touched a record level of $227.21. As of August 13, the cybersecurity company’s stock was changing hands near $225.53, marking a 1.69% daily advance that outperformed the S&P 500’s 0.65% uptick.
Over the trailing year, shares have surged 110.82%. This performance dramatically exceeds the Computer and Technology sector’s modest 0.81% appreciation during the identical timeframe.
Looking at recent momentum, CRWD advanced 7.26% in the most recent 30-day period. During this same window, the S&P 500 posted a 2.38% increase.
The company commands a market capitalization of $229.65 billion. Fundamental metrics show revenue expanding at 23% with gross profit margins reaching 75%, both factors contributing to sustained investor enthusiasm.
From a valuation perspective, shares trade at a forward P/E multiple of 179.88. This represents a significant premium compared to the industry benchmark of 47.24. The PEG ratio stands at 6.49, well above the Security sector norm of 2.73.
InvestingPro analysis suggests the shares may be trading above Fair Value calculations. Nevertheless, this hasn’t dampened bullish sentiment.
Upcoming Quarterly Report
Market attention now shifts to August 26, when CrowdStrike unveils its quarterly financial results. The Street anticipates earnings per share of $0.29, representing a 26.09% increase versus the year-ago period.
Revenue projections for the quarter stand at $1.44 billion, reflecting 23.19% year-over-year growth. Looking at full-year expectations, analysts forecast EPS of $1.23 alongside revenue of $5.94 billion, marking increases of 32.26% and 23.49% respectively.
Zacks Investment Research assigns CRWD a #3 (Hold) rating. The consensus EPS forecast has experienced a modest 0.11% downward revision during the past 30 days.
Wall Street Outlook and Strategic Initiatives
Citizens and Stifel have both upgraded their price objectives to $230. Citizens maintains its Market Outperform stance, highlighting the company’s dominant position in endpoint security. Stifel emphasized AI-powered expansion potential and long-term projections following European investor conferences.
Goldman Sachs researchers have projected substantial growth in AI-focused security expenditures by 2027, a market dynamic that positions CRWD favorably.
In corporate developments, CrowdStrike revealed intentions to purchase XM Cyber’s intellectual property assets, encompassing over 45 patents and proprietary code. This transaction excludes existing revenue streams or customer relationships.
Additionally, CrowdStrike established a strategic alliance with Cerebras Systems aimed at enhancing AI-based threat detection and incident response. Cerebras will deploy the CrowdStrike Falcon platform across its security infrastructure.
The Security industry presently holds a Zacks Industry Rank of 25, positioning it within the top 11% of all monitored sectors.
The post CrowdStrike (CRWD) Stock Reaches Record Peak Before Upcoming Earnings Report appeared first on Blockonomi.